186 related articles for article (PubMed ID: 6871067)
1. The influence of antacid on the absorption of two different sustained-release formulations of theophylline.
Myhre KI; Walstad RA
Br J Clin Pharmacol; 1983 Jun; 15(6):683-7. PubMed ID: 6871067
[TBL] [Abstract][Full Text] [Related]
2. Effect of antacid on bioavailability of a sustained-release theophylline preparation.
Darzentas LJ; Stewart RB; Curry SH; Yost RL
Drug Intell Clin Pharm; 1983; 17(7-8):555-7. PubMed ID: 6872853
[TBL] [Abstract][Full Text] [Related]
3. The rise and fall of serum theophylline concentration: a comparison of sustained-release formulations in volunteers with rapid theophylline clearance.
Mucklow JC; Kuhn S
Br J Clin Pharmacol; 1985 Dec; 20(6):589-96. PubMed ID: 4091990
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the plasma profiles of two slow-release theophylline preparations (Nuelin depot and Theo-dur) in healthy volunteers.
Talseth T; Boye NP; Bredesen JE; Kornstad S
Ann Allergy; 1981 May; 46(5):279-80. PubMed ID: 7235323
[TBL] [Abstract][Full Text] [Related]
5. Lack of influence of an intensive antacid regimen on theophylline bioavailability.
Reed RC; Schwartz HJ
J Pharmacokinet Biopharm; 1984 Jun; 12(3):315-31. PubMed ID: 6502473
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic comparison of a once-daily and twice-daily theophylline delivery system.
González MA; Kisicki J; Straughn AB
Clin Ther; 1994; 16(4):686-92. PubMed ID: 7982257
[TBL] [Abstract][Full Text] [Related]
7. Absorption of theophylline from conventional and sustained-release tablets.
Fagerström PO; Mellstrand T; Svedmyr N
Int J Clin Pharmacol Ther Toxicol; 1981 Mar; 19(3):131-8. PubMed ID: 7228455
[TBL] [Abstract][Full Text] [Related]
8. Comparison of aminophylline and theophylline sustained-release formulations by their bioavailability and steady-state serum levels.
Steinijans VW; Zech K; Fischer R
Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):624-30. PubMed ID: 6668100
[TBL] [Abstract][Full Text] [Related]
9. Effect of an antacid on gastrointestinal absorption of theophylline.
Arnold LA; Spurbeck GH; Shelver WH; Henderson WM
Am J Hosp Pharm; 1979 Aug; 36(8):1059-62. PubMed ID: 484565
[TBL] [Abstract][Full Text] [Related]
10. Absorption of theophylline from conventional and sustained-release tablets.
Mellstrand T; Svedmyr N; Fagerström PO
Eur J Respir Dis Suppl; 1980; 109():54-60. PubMed ID: 6934088
[TBL] [Abstract][Full Text] [Related]
11. Influence of gastric pH changes on pharmacokinetic of a sustained-release formulation of theophylline.
Ferrari M; Olivieri M; Romito D; Biasin C; Barozzi E; Bassetti S
Riv Eur Sci Med Farmacol; 1991; 13(5-6):269-74. PubMed ID: 1819857
[TBL] [Abstract][Full Text] [Related]
12. Absorption of theophylline from enteric coated and sustained release formulations in fasted and non-fasted subjects.
Osman MA; Patel RB; Irwin DS; Welling PG
Biopharm Drug Dispos; 1983; 4(1):63-72. PubMed ID: 6839003
[TBL] [Abstract][Full Text] [Related]
13. Comparison of a sustained-release preparation (Theo-Dur) with a conventional preparation (Nuelin) in the treatment of chronic asthma.
Haahtela T; Vilkka V; Kulstad S
Allergy; 1983 Nov; 38(8):589-92. PubMed ID: 6660438
[TBL] [Abstract][Full Text] [Related]
14. Theophylline QID, TID, BID and now QD? A report on 24-hour dosing with slow-release theophylline formulations with emphasis on analyses of data used to obtain Food and Drug Administration approval for Theo-24.
Weinberger MM
Pharmacotherapy; 1984; 4(4):181-98. PubMed ID: 6483637
[TBL] [Abstract][Full Text] [Related]
15. Effect of antacid on bioavailability of theophylline from rapid and timed-release drug products.
Shargel L; Stevens JA; Fuchs JE; Yu AB
J Pharm Sci; 1981 Jun; 70(6):599-602. PubMed ID: 7252799
[TBL] [Abstract][Full Text] [Related]
16. Effect of sustained-release on the pharmacokinetics of theophylline in healthy subjects.
Bialer M; Salame K; Raz I
Int J Clin Pharmacol Ther Toxicol; 1985 Dec; 23(12):662-7. PubMed ID: 4093206
[TBL] [Abstract][Full Text] [Related]
17. Theophylline absorption from sustained-release products: comparative steady-state bioavailability of once-daily Theo-Dur, Theo-24, and Uniphyl.
Hurwitz A; Karim A; Burns TS
J Clin Pharmacol; 1987 Nov; 27(11):855-61. PubMed ID: 3429692
[TBL] [Abstract][Full Text] [Related]
18. Steady-state evaluation of twice-a-day dosing of a new sustained-release theophylline preparation for young children.
Welch MJ; Kemp JP; Orgel HA; Meltzer EO
J Asthma; 1985; 22(5):249-52. PubMed ID: 4055657
[TBL] [Abstract][Full Text] [Related]
19. Effect of once daily and twice daily sustained release theophylline formulations on daytime variation of bronchial hyperresponsiveness in asthmatic patients.
Ferrari M; Olivieri M; Lampronti G; Bonazza L; Biasin C; Nacci P; Talamini G; Lo Cascio V
Thorax; 1997 Nov; 52(11):969-74. PubMed ID: 9487345
[TBL] [Abstract][Full Text] [Related]
20. Food-induced changes in theophylline absorption from controlled-release formulations. Part I. Substantial increased and decreased absorption with Uniphyl tablets and Theo-Dur Sprinkle.
Karim A; Burns T; Wearley L; Streicher J; Palmer M
Clin Pharmacol Ther; 1985 Jul; 38(1):77-83. PubMed ID: 4006379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
